Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
Takeda's Qdenga has become the first dengue vaccine approved in India, targeting one of the world's most at-risk populations.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
India has approved Qdenga, a vaccine developed by Japanese drugmaker Takeda, as the country's first dengue vaccine. The Central Drugs Standard Control Organisation (DCGI) has cleared the vaccine for individuals between the ages of 4 and 60.
Coverage from Reuters, NDTV, and The Hindu emphasizes the vaccine's eligibility criteria and its role in providing prevention for a high-risk population. The Times of India reports that a city-based private university conducted a chemical trial for the vaccine and notes that immunity remains a challenge due to four different virus strains.
Future developments will likely center on the specific details of effectiveness, dosing, and the rollout for eligible age groups as outlined in reports by NDTV.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Who is eligible for the Qdenga vaccine in India?
The vaccine is approved for individuals aged 4 to 60 years.
Which organization approved the vaccine?
The DCGI cleared the vaccine for use in India.
Who developed the vaccine?
The vaccine was developed by the Japanese drugmaker Takeda.
Coverage (8)
- Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations Taiwan News · 1d ago
- India approves first dengue vaccine Medical Xpress · 1d ago
- City-based pvt varsity conducted dengue vaccine’s chemical trial The Times of India · 1d ago
- India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained NDTV · 1d ago
- India approves first dengue vaccine for individuals aged 4 to 60 years The Hindu · 1d ago
- India approves dengue vaccine: Doctor explains the four virus strains and why immunity remains a major challenge The Times of India · 1d ago
- India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60 The Indian Express · 1d ago
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India Reuters · 1d ago
Topics
Related trends
One of the world's oldest orbicular granites is in India: The 2.56-billion-year-old Pichhore rock is baff
Geologists have identified the Pichhore rock in Madhya Pradesh as one of the oldest orbicular granites on Earth.
Motorola tablet with 9 JBL speakers confirmed to feature 12.1-inch display
Motorola is expanding its hardware lineup with the Moto Pad 70 Groove, a tablet prioritizing audio with a nine-speaker JBL system.
India’s youth-led Cockroach movement vows to continue protest after police crackdown
India's youth-led Cockroach movement pledges to persist in New Delhi despite police interventions involving tear gas and batons.
Samsung Is Under Serious Pressure. Here’s Why It Needs to Nail Its Next Z Fold Phone
Samsung is moving to defend its dominance in the growing foldable market with the upcoming Galaxy Z Fold 8.
India's Gen Z 'Cockroach People's Party' started as satire but is serious about change
India's Gen Z is transforming the satirical 'Cockroach People's Party' into a serious political movement focused on systemic change.
Police attack Cockroach activists as thousands march on Indian parliament
Thousands of youth activists, including the group Cockroach, have marched on the Indian parliament amid violent clashes with police.